Leflunomide/teriflunomide inhibit Epstein-Barr virus (EBV)-induced lymphoproliferative disease and lytic viral replication

Por Bilger, Andrea, Plowshay, Julie, Ma, Shidong, Nawand ar, Dhananjay, Barlow, Elizabeth A., Romero-Masters, James C., Bristol, Jillian A., Li, Zhe, Tsai, Ming-Han, Delecluse, Henri-Jacques, Kenney, Shannon C.
Publicado no Oncotarget (2017)

LMP1-deficient Epstein-Barr virus mutant requires T cells for lymphomagenesis

Por Ma, Shi-Dong, Xu, Xuequn, Plowshay, Julie, Ranheim, Erik A., Burlingham, William J., Jensen, Jeffrey L., Asimakopoulos, Fotis, Tang, Weihua, Gulley, Margaret L., Cesarman, Ethel, Gumperz, Jenny E., Kenney, Shannon C.
Publicado no J Clin Invest (2014)